PG vs RAPP · P/E 25, rev $84.28B vs $532.9M cap
Procter & Gamble Company (PG) versus Rapport Therapeutics, Inc. Common Stock (RAPP) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
RAPP does not have a complete income-statement cache yet.
PG currently screens at market cap $373.53B and trailing P/E 25.3. RAPP currently screens at market cap $532.9M.
Not investment advice. Open the PG and RAPP stock pages for the full models.
Not investment advice.